|
1
|
Perrin PB, Niemeier JP, Mougeot JL, Vannoy
CH, Hirsch MA, Watts JA, Rossman W, Grafton LM, Guerrier TD,
Pershad R, et al: Measures of injury severity and prediction of
acute traumatic brain injury outcomes. J Head Trauma Rehabil.
30:136–142. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Brenner DJ and Hall EJ: Computed
tomography-an increasing source of radiation exposure. N Engl J
Med. 357:2277–2284. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Kmietowicz Z: Better safe than sorry? BMJ.
335:1182–1184. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Majno G and Joris I: Apoptosis, oncosis,
and necrosis. An overview of cell death. Am J Pathol. 146:3–15.
1995.PubMed/NCBI
|
|
5
|
Van Cruchten S and Van Den Broeck W:
Morphological and biochemical aspects of apoptosis, oncosis and
necrosis. Anat Histol Embryol. 31:214–223. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Wang KK: Calpain and caspase: Can you tell
the difference? Trends Neurosci. 23:20–26. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Dressler J, Hanisch U, Kuhlisch E and
Geiger KD: Neuronal and glial apoptosis in human traumatic brain
injury. Int J Legal Med. 121:365–375. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Castillo MR and Babson JR:
Ca(2+)-dependent mechanisms of cell injury in cultured cortical
neurons. Neuroscience. 86:1133–1144. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Rathmell JC and Thompson CB: The central
effectors of cell death in the immune system. Annu Rev Immunol.
17:781–828. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Raghupathi R: Cell death mechanisms
following traumatic brain injury. Brain Pathol. 14:215–222. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Newcomb JK, Kampfl A, Posmantur RM, Zhao
X, Pike BR, Liu SJ, Clifton GL and Hayes RL: Immunohistochemical
study of calpain-mediated breakdown products to alpha-spectrin
following controlled cortical impact injury in the rat. J
Neurotrauma. 14:369–383. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Wang KK, Posmantur R, Nath R, McGinnis K,
Whitton M, Talanian RV, Glantz SB and Morrow JS: Simultaneous
degradation of alphaII- and betaII-spectrin by caspase 3 (CPP32) in
apoptotic cells. J Biol Chem. 273:22490–22497. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Valiyaveettil M, Alamneh YA, Wang Y, Arun
P, Oguntayo S, Wei Y, Long JB and Nambiar MP: Cytoskeletal protein
α-II spectrin degradation in the brain of repeated blast exposed
mice. Brain Res. 1549:32–41. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Pike BR, Flint J, Dave JR, Lu XC, Wang KK,
Tortella FC and Hayes RL: Accumulation of calpain and caspase-3
proteolytic fragments of brain-derived alphaII-spectrin in cerebral
spinal fluid after middle cerebral artery occlusion in rats. J
Cereb Blood Flow Metab. 24:98–106. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Ringger NC, Tolentino PJ, McKinsey DM,
Pike BR, Wang KK and Hayes RL: Effects of injury severity on
regional and temporal mRNA expression levels of calpains and
caspases after traumatic brain injury in rats. J Neurotrauma.
21:829–841. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Wilson JT, Pettigrew LE and Teasdale GM:
Structured interviews for the Glasgow Outcome Scale and the
extended Glasgow Outcome Scale: Guidelines for their use. J
Neurotrauma. 15:573–585. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Narayan RK, Greenberg RP, Miller JD, Enas
GG, Choi SC, Kishore PR, Selhorst JB, Lutz HA 3rd and Becker DP:
Improved confidence of outcome prediction in severe head injury. A
comparative analysis of the clinical examination, multimodality
evoked potentials, CT scanning, and intracranial pressure. J
Neurosurg. 54:751–762. 1981. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Choi SC, Clifton GL, Marmarou A and Miller
ER: Misclassification and treatment effect on primary outcome
measures in clinical trials of severe neurotrauma. J Neurotrauma.
19:17–22. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Reeves TM, Greer JE, Vanderveer AS and
Phillips LL: Proteolysis of submembrane cytoskeletal proteins
ankyrin-G and αII-spectrin following diffuse brain injury: A role
in white matter vulnerability at nodes of ranvier. Brain Pathol.
20:1055–1068. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Schoch KM, von Reyn CR, Bian J, Telling
GC, Meaney DF and Saatman KE: Brain injury-induced proteolysis is
reduced in a novel calpastatin-overexpressing transgenic mouse. J
Neurochem. 125:909–920. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Zhang Z, Larner SF, Liu MC, Zheng W, Hayes
RL and Wang KK: Multiple alphaII-spectrin breakdown products
distinguish calpain and caspase dominated necrotic and apoptotic
cell death pathways. Apoptosis. 14:1289–1298. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Pike BR, Flint J, Dutta S, Johnson E, Wang
KK and Hayes RL: Accumulation of non-erythroid alpha II-spectrin
and calpain- cleaved alpha II-spectrin breakdown products in
cerebrospinal fluid after traumatic brain injury in rats. J
Neurochem. 78:1297–1306. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Cardali S and Maugeri R: Detection of
alphaII-spectrin and breakdown products in humans after severe
traumatic brain injury. J Neurosurg Sci. 50:25–31. 2006.PubMed/NCBI
|
|
24
|
Pineda JA, Lewis SB, Valadka AB, Papa L,
Hannay HJ, Heaton SC, Demery JA, Liu MC, Aikman JM, Akle V, et al:
Clinical significance of alphaII-spectrin breakdown products in
cerebrospinal fluid after severe traumatic brain injury. J
Neurotrauma. 24:354–366. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Farkas O, Polgár B, Szekeres-Barthó J,
Dóczi T, Povlishock JT and Büki A: Spectrin breakdown products in
the cerebrospinal fluid in severe head injury-preliminary
observations. Acta Neurochir (Wien). 147:855–861. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Schober ME, Requena DF, Davis LJ, Metzger
RR, Bennett KS, Morita D, Niedzwecki C, Yang Z and Wang KK: Alpha
II Spectrin breakdown products in immature Sprague Dawley rat
hippocampus and cortex after traumatic brain injury. Brain Res.
1574:105–112. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Brophy GM, Pineda JA, Papa L, Lewis SB,
Valadka AB, Hannay HJ, Heaton SC, Demery JA, Liu MC, Tepas JJ III,
et al: alphaII-Spectrin breakdown product cerebrospinal fluid
exposure metrics suggest differences in cellular injury mechanisms
after severe traumatic brain injury. J Neurotrauma. 26:471–479.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Pike BR, Flint J, Dutta S, Johnson E, Wang
KK and Hayes RL: Accumulation of non-erythroid alpha II-spectrin
and calpain-cleaved alpha II-spectrin breakdown products in
cerebrospinal fluid after traumatic brain injury in rats. J
Neurochem. 78:1297–1306. 2001. View Article : Google Scholar : PubMed/NCBI
|
